These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The leukemoid reaction in shigellosis. Butler T; Islam MR; Bardhan PK Am J Dis Child; 1984 Feb; 138(2):162-5. PubMed ID: 6695872 [TBL] [Abstract][Full Text] [Related]
7. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease. Islam D; Bardhan PK; Lindberg AA; Christensson B Infect Immun; 1995 Aug; 63(8):2941-9. PubMed ID: 7622216 [TBL] [Abstract][Full Text] [Related]
8. Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. Koster F; Levin J; Walker L; Tung KS; Gilman RH; Rahaman MM; Majid MA; Islam S; Williams RC N Engl J Med; 1978 Apr; 298(17):927-33. PubMed ID: 642973 [TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome associated with shigellosis: report of two cases. Rongnoparat C; Panpanit R Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):226-8. PubMed ID: 3313740 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to Shiga toxin in the serum of children with Shigella-associated haemolytic uraemic syndrome. Azim T; Rashid A; Qadri F; Sarker MS; Hamadani J; Salam MA; Wahed MA; Albert MJ J Med Microbiol; 1999 Jan; 48(1):11-16. PubMed ID: 9920120 [TBL] [Abstract][Full Text] [Related]
11. Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis. Islam D; Wretlind B; Lindberg AA; Christensson B Infect Immun; 1996 Apr; 64(4):1391-9. PubMed ID: 8606106 [TBL] [Abstract][Full Text] [Related]
12. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. Bennish ML; Khan WA; Begum M; Bridges EA; Ahmed S; Saha D; Salam MA; Acheson D; Ryan ET Clin Infect Dis; 2006 Feb; 42(3):356-62. PubMed ID: 16392080 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood granulocytes and mononuclear cell responses in monkeys with experimental shigellosis. Islam LN; Ferdous A; Azim T; Qadri F; Rahman A; Islam MS; Tzipori S J Diarrhoeal Dis Res; 1994 Jun; 12(2):97-102. PubMed ID: 7963351 [TBL] [Abstract][Full Text] [Related]
14. Clinical features, including haemolytic-uraemic syndrome, in Shigella dysenteriae type 1 infection in children of Rangoon. Khin-Maung-U ; Myo-Khin ; Tin-Aye ; Myo-Min-Aung ; Soe-Soe-Aye ; Thane-Oke-Kyaw-Myint ; Khin-Than-Nu J Diarrhoeal Dis Res; 1987 Sep; 5(3):175-7. PubMed ID: 3333769 [No Abstract] [Full Text] [Related]
15. Risk factors for development of hemolytic uremic syndrome during shigellosis. Butler T; Islam MR; Azad MA; Jones PK J Pediatr; 1987 Jun; 110(6):894-7. PubMed ID: 3295160 [No Abstract] [Full Text] [Related]
16. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Bhimma R; Rollins NC; Coovadia HM; Adhikari M Pediatr Nephrol; 1997 Oct; 11(5):560-4. PubMed ID: 9323280 [TBL] [Abstract][Full Text] [Related]
17. Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. de Silva DG; Mendis LN; Sheron N; Alexander GJ; Candy DC; Chart H; Rowe B Gut; 1993 Feb; 34(2):194-8. PubMed ID: 8432472 [TBL] [Abstract][Full Text] [Related]
18. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Tsegaye A; Wolday D; Otto S; Petros B; Assefa T; Alebachew T; Hailu E; Adugna F; Measho W; Dorigo W; Fontanet AL; van Baarle D; Miedema F Clin Immunol; 2003 Dec; 109(3):338-46. PubMed ID: 14697749 [TBL] [Abstract][Full Text] [Related]